| 1 | branch of top notch | | | | | | | 2 | 0.94% |
| 2 | board statistics newsroom news | | | | | | | 2 | 0.94% |
| 3 | through the health sector | | | | | | | 2 | 0.94% |
| 4 | the health sector rd | | | | | | | 2 | 0.94% |
| 5 | research environment finland research | | | | | | | 2 | 0.94% |
| 6 | pharmaceutical research and product | | | | | | | 2 | 0.94% |
| 7 | experts joint fight against | | | | | | | 2 | 0.94% |
| 8 | medicinal products registerbased studies | | | | | | | 2 | 0.94% |
| 9 | products registerbased studies rwd | | | | | | | 2 | 0.94% |
| 10 | hospital medicines vaccines selfcare | | | | | | | 2 | 0.94% |
| 11 | medicines vaccines selfcare medicines | | | | | | | 2 | 0.94% |
| 12 | personnel media contacts feedback | | | | | | | 2 | 0.94% |
| 13 | biosimilars marketing authorisation medicine | | | | | | | 2 | 0.94% |
| 14 | blogs events statistics contact | | | | | | | 2 | 0.94% |
| 15 | medicines distribution of pharmaceuticals | | | | | | | 2 | 0.94% |
| 16 | pharmaceutical manufacturing medicines safety | | | | | | | 2 | 0.94% |
| 17 | functional capacity savings in | | | | | | | 2 | 0.94% |
| 18 | manufacturing medicines safety medicines | | | | | | | 2 | 0.94% |
| 19 | pif members the pif | | | | | | | 2 | 0.94% |
| 20 | do pif members the | | | | | | | 2 | 0.94% |
| 21 | we do pif members | | | | | | | 2 | 0.94% |
| 22 | what we do pif | | | | | | | 2 | 0.94% |
| 23 | system marketing cooperation with | | | | | | | 2 | 0.94% |
| 24 | marketing cooperation with healthcare | | | | | | | 2 | 0.94% |
| 25 | is what we do | | | | | | | 2 | 0.94% |
| 26 | this is what we | | | | | | | 2 | 0.94% |
| 27 | and the environment pharmaceutical | | | | | | | 2 | 0.94% |
| 28 | the environment pharmaceutical industry | | | | | | | 2 | 0.94% |
| 29 | we are we influence | | | | | | | 2 | 0.94% |
| 30 | resistance we are we | | | | | | | 2 | 0.94% |
| 31 | – branch of top | | | | | | | 2 | 0.94% |
| 32 | overall expenditure economic growth | | | | | | | 2 | 0.94% |
| 33 | research and product development | | | | | | | 2 | 0.94% |
| 34 | joint fight against antibiotic | | | | | | | 2 | 0.94% |
| 35 | health through innovation working | | | | | | | 2 | 0.94% |
| 36 | government backing land of | | | | | | | 2 | 0.94% |
| 37 | centers value of medicines | | | | | | | 2 | 0.94% |
| 38 | and culture of trust | | | | | | | 2 | 0.94% |
| 39 | people and culture of | | | | | | | 2 | 0.94% |
| 40 | backing land of specialised | | | | | | | 2 | 0.94% |